Virios therapeutics to report fourth quarter and full year 2021 financial results and provide corporate update on thursday, march 17, 2022

Atlanta--(business wire)---- $viri #biotech--virios therapeutics, inc. (nasdaq: viri), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat chronic diseases, including fibromyalgia, announced today that its fourth quarter and full year 2021 financial results will be reported on thursday, march 17, 2022 before the open of the financial markets. management will also host a webcast and conference call on march 17, 2022 at 8:30 a.m. et to discuss the results and provide a
VIRI Ratings Summary
VIRI Quant Ranking